Company intelligence / Profile preview

Microsynth

Balgach, Switzerland

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Microsynth provides high-quality DNA/RNA synthesis, sequencing, analysis services—including Sanger and next-generation sequencing—and contract research solutions. The company holds ISO certifications and SwissMedic GMP authorization for quality control of medicinal products by Sanger sequencing. It serves pharma, biotech, academia, diagnostics developers, and researchers across Europe with more than three decades of expertise in nucleic acid technologies.

Modalities: Antisense oligonucleotideSmall interfering RNAAptamerDNA oligonucleotide (for research/diagnostics)RNA oligonucleotide (for research/diagnostics)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Microsynth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microsynth.

Explore the full profile